Objectives: To determine the indications for cerebral function monitoring, the characteristics of babies who had CFM and their outcomes at discharge. Methods: The records of all term newborn babies ...
The use of cerebral oximetry monitoring in the care of extremely preterm infants is increasing. However, evidence that its use improves clinical outcomes is lacking. In this randomized, phase 3 trial ...
The evidence indicates that non-invasive monitoring (near-infrared spectroscopy; NIRS) of oxygen in brain tissue likely does not reduce death rates or short-term brain problems for very premature ...
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) announced today that O3 ® Regional Oximetry has received FDA clearance for use on neonatal and infant patients (<10 kg). O3 may help clinicians ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback